AccScience Publishing / JCBP / Online First / DOI: 10.36922/jcbp.2848
CASE REPORT

Anxiety and depression in a patient with an implantable cardioverter defibrillator for early repolarization syndrome: A case report and clinical discussion

Yue Sun1 Zhiming Yu1*
Show Less
1 Department of Cardiology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China
Submitted: 30 January 2024 | Accepted: 16 April 2024 | Published: 10 July 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Early repolarization syndrome (ERS) was initially thought to be a good prognostic manifestation detectable by electrocardiogram. In recent years, with the gradual deepening of research and understanding, ERS is considered to possess malignant tendency and related to ventricular fibrillation (VF) and sudden cardiac death (SCD). Implantable cardioverter defibrillator (ICD) is currently the first choice of treatment used to reduce the risk of potentially life-threatening arrhythmias and SCD in patients at high risk for ERS. The stress of living with an implanted device and receiving ICD shock has been noted to exert a psychological toll on patients, especially those who have previously experienced VF and syncope. The current case report describes symptoms and signs of a patient with ERS, and discusses the changes of psychological condition after ICD implantation. Moreover, we explored a targeted treatment approach for anxiety and depression in an individual with an ICD for ERS, which combined medication, cognitive behavioral therapy, and physical exercise. We believe that the psychological experience of ICD recipients, which is a critical component in designing the biopsychosocial therapeutic approach for this growing patient population, is worthy of more attention.

Keywords
Cardiology
Early repolarization syndrome
Implantable cardioverter defibrillator
Ventricular fibrillation
Anxiety
Depression
Funding
This work was supported by the Health Commission of Jiangsu Province (Grant: LKM2023031) and “TAIHU” talent program (Grant: 2023XSMZL-GD-YZM-2023).
References
  1. Bourier F, Denis A, Cheniti G, et al. Early repolarization syndrome: Diagnostic and therapeutic approach. Front Cardiovasc Med. 2018;5:169. doi: 10.3389/fcvm.2018.00169

 

  1. Antzelevitch C, Yan GX. J wave syndromes. Heart Rhythm. 7(4):549-558. doi: 10.1016/j.hrthm.2009.12.006

 

  1. Krahn AD, Tfelt-Hansen J, Tadros R, Steinberg C, Semsarian C, Han HC. Latent causes of sudden cardiac arrest. JACC Clin Electrophysiol. 2022;8(6):806-821. doi: 10.1016/j.jacep.2021.12.014

 

  1. Habibović M, Pedersen SS, Broers ER, et al. Prevalence of anxiety and risk associated with ventricular arrhythmia in patients with an implantable cardioverter defibrillator. Int J Cardiol. 2020;310:80-85. doi: 10.1016/j.ijcard.2020.02.005

 

  1. Lindekilde N, Skov O, Skovbakke SJ, Johansen JB, NielsencJC, Pedersen SS. Anxiety and depression as risk factors for ICD shocks and mortality in patients with an implantable cardioverter defibrillator-a systematic review. Gen Hosp Psychiatry. 2022;78:96-107. doi: 10.1016/j.genhosppsych.2022.07.008

 

  1. Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/ APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-1963. doi: 10.1093/europace/eut272.

 

  1. Wong MF. Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator. J Clin Nurs. 2017;26(9-10):1328-1337. doi: 10.1111/jocn.13637

 

  1. Ghezzi ES, Sharman RL, Selvanayagam JB, et al. Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: A systematic review and meta-analysis of 39 954 patients. Europace. 2023;25(6):euad130. doi: 10.1093/europace/euad130

 

  1. Perini AP, Kutyifa V, Veazie P, et al. Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy. Am Heart J. 2017;189:75-84. doi: 10.1016/j.ahj.2017.03.009

 

  1. Fumagalli S, Pieragnoli P, Haugaa KH, et al. The influence of age on the psychological profile of patients with cardiac implantable electronic devices: Results from the Italian population in a multicenter study conducted by the European heart rhythm association. Aging Clin Exp Res. 2019;31(9):1219-1226. doi: 10.1007/s40520-018-1088-5

 

  1. Pedersen SS, Nielsen JC, Wehberg S, et al. New onset anxiety and depression in patients with an implantable cardioverter defibrillator during 24 months of follow-up (data from the national DEFIB-WOMEN study). Gen Hosp Psychiatry. 2021;72:59-65. doi: 10.1093/europace/euab116.424.

 

  1. Dubovsky SL, Marshall D. Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother Psychosom. 2022;91(5):307-334. doi: 10.1159/000524400

 

  1. Kahl KG, Stapel B, Correll CU. Psychological and psychopharmacological interventions in psychocardiology. Front Psychiatry. 2022;13:831359. doi: 10.3389/FPSYT.2022.831359

 

  1. Wu CS, Tsai YT, Hsiung CA, Tsai HJ. Comparative risk of ventricular arrhythmia and sudden cardiac death across antidepressants in patients with depressive disorders. J Clin Psychopharmacol. 2017;37(1):32-39. doi: 10.1097/JCP.0000000000000631

 

  1. Leppert F, Siebermair J, Wesemann U. The influence of remote monitoring on anxiety/depression, quality of life, and device acceptance in ICD patients: A prospective, randomized, controlled, single-center trial. Clin Res Cardiol. 2021;110(6):789-800. doi: 10.1007/s00392-020-01667-0

 

  1. Berg SK, Rasmussen TB, Herning M, et al. Cognitive behavioural therapy significantly reduces anxiety in patients with implanted cardioverter defibrillator compared with usual care: Findings from the Screen-ICD randomised controlled trial. Eur J Prev Cardiol. 2020;27(3):258-268. doi: 10.1177/2047487319874147.

 

  1. Aditee D, Pankaj M, Neil B, et al. Meditation for improved clinical outcomes in patients with implantable defibrillators for heart failure-pilot study. J Atr Fibrillation. 2020;12(6):2314. doi: 10.4022/jafib.2314

 

  1. Saeed SA, Cunningham K, Bloch RM. Depression and anxiety disorders: Benefits of exercise, yoga, and meditation. Am Fam Physician. 2019;99(10):620-627.

 

  1. Dougherty CM, Burr RL, Kudenchuk PJ, Glenny RW. Aerobic exercise effects on quality of life and psychological distress after an implantable cardioverter defibrillator. J Cardiopulm Rehabil Prev. 2020;40(2):94-101. doi: 10.1097/HCR.0000000000000444
Conflict of interest
The authors declare that they have no competing interests.
Share
Back to top
Journal of Clinical and Basic Psychosomatics, Electronic ISSN: 2972-4414 Published by AccScience Publishing